How To Attend BioXcel Therapeutics Q1 2022 Earnings Conference Call
BioXcel Therapeutics (NASDAQ:BTAI) will host a conference call at 08:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results.
BioXcel Therapeutics Announces Formation Of OnkosXcel Therapeutics To Develop Medicines Focused In Oncology
OnkosXcel, a Company subsidiary, to utilize proprietary AI-powered platform to progress therapies to address difficult-to-treat cancers with high unmet need
New structure to unlock growth opportunities and
Looking Into Bioxcel Therapeutics Inc’s Recent Short Interest
Bioxcel Therapeutics Inc's (NASDAQ:BTAI) short percent of float has risen 10.66% since its last report. The company recently reported that it has 1.87 million shares sold short, which is 9.86% of all regular shares that are available for trading.
Benzinga’s Daily Brief On Trending Tickers For April 7, 2022: SDPR S&P 500, Houghton Mifflin, Sunshine Biopharma And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the
40 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales and development agreement.
Why BioXcel Therapeutics Stock Is Surging Today
BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are trading higher Wednesday after the company announced that the U.S.
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that moved stocks during the week.